Among the signaling systems that are compromised in the brain of Alzheimer's patients is the so called cholinergic system and there arereceptors within this system that can be stimulated by nicotine, which is present in tobacco. Thus, in theory, nicotine could "boost" this system tocompensate (at least for a certain amount of time) for its deterioration inAlzheimer's disease. Nicotine has also been found to increase alertness andenhance learning and memory. So, the argument grew that cigarettes, beingin effect a nicotine delivery system, could be helpful in Alzheimer's disease.Indeed, several studies have found that smoking in different contexts reducesthe risk of Alzheimer's disease and this notion has made its way to the lay press and cyberspace.But these claims have been controversial as many consider that the harmfulchemicals in tobacco would likely outweigh any positive effects of nicotine,and even if nicotine were found to be beneficial there are safer and moreefficient means of delivering it to the body than through cigarette smoke.However, the fact remains that, for the majority of people, the most commonnicotine delivery vehicle is smoking. Not surprisingly the tobacco industryhas funded research into this matter for the past two decades.In a recent article published in the Journal of Alzheimer's Disease by JanineCataldo, Judith Prochaska and Staunton Glantz, researchers of the Universityof California, San Francisco (UCSF), the authors did something that previous researchers in the field of Alzheimer's disease had not done. Normally when you perform a statistical evaluation of the scientificliterature regarding a certain topic you want to account for all the variablesthat can affect the outcome of the studies you are reviewing. This is called